Skip to main content
SpringerLink
Log in

Content validity and legacy patient-reported outcome measures in cancer

  • Commentary
  • Published:
Quality of Life Research Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. US Department of Health and Human Services. Guidance for industry: Patient-reported outcome measures: use in medical product development to support labeling claims. December 2009, http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM193282.pdf.

  2. DeMuro, C., Clark, M., Mordin, M., Fehnel, S., Copley-Merriman, C., & Gnanasakthy, A. (2012). Reasons for rejection of patient-reported outcome label claims: A compilation based on a review of patient-reported outcome use among new molecular entities and biologic license applications, 2006–2010. Value in Health., 15, 443–448.

    Article  PubMed  Google Scholar 

  3. Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., et al. (1993). The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute, 85, 365–376.

    Article  CAS  PubMed  Google Scholar 

  4. Basch, E., Abernethy, A. P., Mullins, C. D., Reeve, B. B., Smith, M. L., Coons, S. J., et al. (2012). Recommendations for incorporating patient-reported outcomes into clinical comparative effectiveness research in adult oncology. Journal of Clinical Oncology, 30, 4249–4255.

    Article  PubMed  Google Scholar 

  5. Velikova, G., Booth, L., Smith, A. B., Brown, P. M., Lynch, P., Brown, J. M., & Selby, P. J. (2004). Measuring quality of life in routine oncology practice improves communication and patient well-being: A randomized controlled trial. Journal of Clinical Oncology, 22, 714–724.

    Article  PubMed  Google Scholar 

  6. DeMuro, C., Clark, M., Doward, L., Evans, E., Mordin, M., & Gnanasakthy, A. (2013). Assessment of PRO label claims granted by the FDA as compared to the EMA (2006–2010). Value in Health, 16, 1150–1155.

    Article  PubMed  Google Scholar 

  7. EORTC Quality of Life Group. Guidelines for developing questionnaire modules 2011. Accessed October 28, 2014, http://groups.eortc.be/qol/manuals.

  8. Reeve, B.B., Mitchell, S.A., Dueck, A.C., Basch, E., Cella, D., Reilly, C.M., Minasian, L.M., Denicoff, A.M., O’Mara, A.M., Fisch, M.J., Chauhan, C., Aaronson, N.K., Coens, C., Bruner, D.W. (2014). Recommended patient-reported core set of symptoms to measure in adult cancer treatment trials. Journal of National Cancer Institute, 106(7).

Download references

Author information

Authors and Affiliations

  1. York Health Economics Consortium, Market Square, University of York, York, YO10 5NH, UK

    Adam B. Smith

  2. York Trials Unit, Department of Health Sciences, University of York, York, YO10 5DD, UK

    Kim Cocks

Authors
  1. Adam B. Smith
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kim Cocks
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Adam B. Smith.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Smith, A.B., Cocks, K. Content validity and legacy patient-reported outcome measures in cancer. Qual Life Res 24, 1585–1586 (2015). https://doi.org/10.1007/s11136-014-0890-6

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11136-014-0890-6

Keywords

Search

Navigation